Selinexor‐based Regimens for the Treatment of Myeloma Refractory to Chimeric Antigen Receptor T Cell Therapy
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.16550
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 2, 2020
Authors
Publisher
Wiley